4//SEC Filing
BRADLEY PHARMACEUTICALS INC 4
Accession 0000864268-03-000075
CIK 0000864268operating
Filed
Aug 7, 8:00 PM ET
Accepted
Aug 8, 12:07 PM ET
Size
8.9 KB
Accession
0000864268-03-000075
Insider Transaction Report
Form 4
GLASSMAN BRADLEY
Senior VP - Sales & Marketing
Transactions
- Discretionary Transaction
Common Stock
2003-07-11$17.09/sh+59$1,008→ 15,497 total(indirect: By 401(k))
Holdings
- 25,344
Common Stock
- 3,305
Stock Options (Right to buy)
Exercise: $8.81From: 2003-07-09Exp: 2004-07-08→ Common Stock (3,305 underlying) - 1,326
Stock Options (Right to buy)
Exercise: $10.58From: 2003-07-09Exp: 2006-07-08→ Common Stock (1,326 underlying) - 15,620(indirect: By Trust)
Common Stock
- 20,880(indirect: By Trust)
Class B Common Stock
- 12,000
Stock Options (Right to buy)
Exercise: $1.38From: 2003-12-08Exp: 2010-12-07→ Common Stock (12,000 underlying) - 3,232(indirect: By 401(k))
Common Stock
- 60,000
Stock Options (Right to buy)
Exercise: $7.05From: 2004-07-09Exp: 2011-07-08→ Common Stock (60,000 underlying)
Documents
Issuer
BRADLEY PHARMACEUTICALS INC
CIK 0000864268
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0000864268
Filing Metadata
- Form type
- 4
- Filed
- Aug 7, 8:00 PM ET
- Accepted
- Aug 8, 12:07 PM ET
- Size
- 8.9 KB